Oncobiologics Inc. | Ownership
Companies that own Oncobiologics Inc.
Sabby Capital LLC
3,692,737
5.12%
1,584,488
1.57%
06/30/2018
venBio Select Advisor LLC
683,531
0.95%
0
0.02%
06/30/2018
The Vanguard Group, Inc.
309,037
0.43%
-3,670
0%
06/30/2018
Marshall Wace North America LP
261,800
0.36%
0
0%
06/30/2018
PanAgora Asset Management, Inc.
60,087
0.08%
2,925
0%
06/30/2018
Acuta Capital Partners LLC
29,082
0.04%
0
0%
06/30/2018
Two Sigma Securities LLC
22,805
0.03%
-229
0%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
16,011
0.02%
0
0%
06/30/2018
Geode Capital Management LLC
11,165
0.02%
0
0%
06/30/2018
Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)
10,000
0.01%
0
0%
06/30/2018
| Address |
7 Clarke Drive
Cranbury New Jersey 08512
United States
|
|
Employees
|
- |
| Website |
http://www.oncobiologics.com |
| Updated |
09/14/2018 |
| Oncobiologics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ. |
